Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Bristol Myers Squibb Receives Positive CHMP Opinion for Zeposia (ozanimod) as a Treatment for Adult Patients with Moderately to Severely Active Ulcerative Colitis
Bristol Myers Squibb (NYSE:BMY) today announced the Committee for Medicinal Products for Human Use (CHMP) of […]
Lateral Flow Tests to be Introduced for Vaccinated International Arrivals
Eligible fully vaccinated passengers arriving in England from countries not on the red list can […]
Illumina Appoints Bob Ragusa as Chief Executive Officer (CEO) of GRAIL
Illumina, Inc. (NASDAQ:ILMN) today announced that Bob Ragusa has been appointed as Chief Executive Officer of GRAIL, […]
Roche Announces PathAI Collaboration for Artificial Intelligence-based Digital Pathology Applications for Improved Patient Care
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has entered an agreement with PathAI, […]
Labster to Acquire World's First VR Training Platform for Nursing
Labster, the world’s leading platform for virtual labs and interactive science, today announced it has […]
BICO Strengthens IP Portfolio with Patents in the United States and Sweden for 3D Bioprinting of Temperature Sensitive Bioinks
BICO, the world’s leading bio convergence company, has been granted two patents relating to the […]
ScienceIO Launches with $8 Million Seed to Fix Healthcare's Data Problem
ScienceIO, the data science company transforming healthcare, emerged from stealth mode today with $8 million in seed […]
MindMaze and The Royal Buckinghamshire Hospital Pioneer First U.K. Location-based Digital Therapeutic Solution for Brain Repair
MindMaze Healthcare, the category leader in the multibillion-dollar digital neurotherapeutics market, today announced the first […]
LEXEO Therapeutics and FUJIFILM Diosynth Biotechnologies Announce Collaboration to Support Development and Manufacturing of Gene Therapies for Genetic Diseases
LEXEO Therapeutics, a fully integrated clinical-stage gene therapy company advancing adeno-associated virus (AAV)-mediated treatments for […]
Dotmatics Partners with RockStep Solutions to Provide an Integrated Solution for Digitalized in Vivo Drug Discovery
Dotmatics Ltd, an Insightful Science company that provides leading-edge scientific informatics software to drive the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more